[Prevalence and demographic factors associated with ferritin deficiency in Colombian children, 2010]

Robinson Ramírez-Vélez1, Javier Matínez-Torres2, José Francisco Meneses-Echavez1

  • 1Facultad de Cultura Física, Deporte y Recreación, Universidad Santo Tomás, Bogotá, Colombia.

Insights

In Colombia, 10.6% of children under five have ferritin deficiency, a condition linked to age, indigenous ethnicity, and specific regions. Targeted nutritional and educational interventions are recommended to address this public health issue.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Public Health

Context:

  • Ferritin deficiency is a significant global health concern, particularly in developing nations.
  • Understanding its prevalence and associated factors is crucial for effective public health strategies.
  • Colombia's National Survey on the Nutritional Situation (ENSIN) provides valuable data for such analyses.

Purpose:

  • To determine the prevalence of ferritin deficiency in Colombian children aged 12-59 months.
  • To identify socio-demographic factors associated with ferritin deficiency in this population.

Summary:

  • A cross-sectional analysis of 3542 children revealed a ferritin deficiency prevalence of 10.6%.
  • Key risk factors included younger age groups (12-23 and 24-35 months), indigenous ethnicity, and residence in the Atlantic or Pacific regions.
  • Average ferritin levels were 32.1 g/L, with deficiency defined as <12 ug/L.

Impact:

  • The findings highlight significant disparities and risk factors for ferritin deficiency in Colombian children.
  • Results underscore the need for comprehensive interventions combining nutritional support and education.
  • This research can inform targeted public health policies to combat iron deficiency anemia.
Abstract

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
8.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
544
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
228
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
470
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405